Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Howie, H.
and
Hutchinson, S. J.
2004.
What lies ahead and can we afford it?.
Journal of Viral Hepatitis,
Vol. 11,
Issue. s1,
p.
28.
Goldberg, D.
and
Anderson, E.
2004.
Hepatitis C: who is at risk and how do we identify them?.
Journal of Viral Hepatitis,
Vol. 11,
Issue. s1,
p.
12.
Hutchinson, Sharon J.
Bird, Sheila M.
and
Goldberg, David J.
2005.
Modeling the Current and Future Disease Burden of Hepatitis C Among Injection Drug Users in Scotland *.
Hepatology,
Vol. 42,
Issue. 3,
p.
711.
Judd, A.
Hutchinson, S.
Wadd, S.
Hickman, M.
Taylor, A.
Jones, S.
Parry, J. V.
Cameron, S.
Rhodes, T.
Ahmed, S.
Bird, S.
Fox, R.
Renton, A.
Stimson, G.V.
and
Goldberg, D.
2005.
Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
Journal of Viral Hepatitis,
Vol. 12,
Issue. 6,
p.
655.
McIntyre, PG
Tosh, K
McGuire, W
and
McGuire, William
2005.
Cochrane Database of Systematic Reviews.
Hutchinson, Sharon J.
Bird, Sheila M.
Taylor, Avril
and
Goldberg, David J.
2006.
Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: Implications for prevention.
International Journal of Drug Policy,
Vol. 17,
Issue. 3,
p.
211.
Hutchinson, SJ
Roy, KM
Wadd, S
Bird, SM
Taylor, A
Anderson, E
Shaw, L
Codere, G
and
Goldberg, DJ
2006.
Hepatitis C Virus Infection in Scotland: Epidemiological Review and Public Health Challenges.
Scottish Medical Journal,
Vol. 51,
Issue. 2,
p.
8.
Parkes, Julie
Roderick, Paul
Bennett-Lloyd, Bethan
and
Rosenberg, William
2006.
Variation in Hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom.
BMC Public Health,
Vol. 6,
Issue. 1,
McIntyre, Paul G
Tosh, Karen
and
McGuire, William
2006.
Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission.
Cochrane Database of Systematic Reviews,
Vol. 2010,
Issue. 6,
van den Berg, Charlotte H. S. B.
Smit, Colette
Bakker, Margreet
Geskus, Ronald B.
Berkhout, Ben
Jurriaans, Suzanne
Coutinho, Roel A.
Wolthers, Katja C.
and
Prins, Maria
2007.
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.
European Journal of Epidemiology,
Vol. 22,
Issue. 3,
p.
183.
Vickerman, P
Hickman, M
and
Judd, A
2007.
Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.
International Journal of Epidemiology,
Vol. 36,
Issue. 2,
p.
396.
Berkley, Eliza M. F.
Leslie, Kimberly K.
Arora, Sanjeev
Qualls, Clifford
and
Dunkelberg, Jeffrey C.
2008.
Chronic Hepatitis C in Pregnancy.
Obstetrics & Gynecology,
Vol. 112,
Issue. 2,
p.
304.
BALOGUN, M. A.
VYSE, A. J.
HESKETH, L. M.
KAFATOS, G.
PARRY, J. V.
and
RAMSAY, M. E.
2009.
Estimating hepatitis C infection acquired in England, 1986–2000.
Epidemiology and Infection,
Vol. 137,
Issue. 9,
p.
1249.
Sweeting, M. J.
Hope, V. D.
Hickman, M.
Parry, J. V.
Ncube, F.
Ramsay, M. E.
and
De Angelis, D.
2009.
Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?.
American Journal of Epidemiology,
Vol. 170,
Issue. 3,
p.
352.
Palmateer, Norah
Kimber, Jo
Hickman, Matthew
Hutchinson, Sharon
Rhodes, Tim
and
Goldberg, David
2010.
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Addiction,
Vol. 105,
Issue. 5,
p.
844.
Turner, Katy M. E.
Hutchinson, Sharon
Vickerman, Peter
Hope, Vivian
Craine, Noel
Palmateer, Norah
May, Margaret
Taylor, Avril
De Angelis, Daniela
Cameron, Sheila
Parry, John
Lyons, Margaret
Goldberg, David
Allen, Elizabeth
and
Hickman, Matthew
2011.
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
Addiction,
Vol. 106,
Issue. 11,
p.
1978.
Lavanchy, D.
2011.
Evolving epidemiology of hepatitis C virus.
Clinical Microbiology and Infection,
Vol. 17,
Issue. 2,
p.
107.
Martin, Natasha K.
Vickerman, Peter
Foster, Graham R.
Hutchinson, Sharon J.
Goldberg, David J.
and
Hickman, Matthew
2011.
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.
Journal of Hepatology,
Vol. 54,
Issue. 6,
p.
1137.
Vickerman, Peter
Martin, Natasha
Turner, Katy
and
Hickman, Matthew
2012.
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.
Addiction,
Vol. 107,
Issue. 11,
p.
1984.
Allen, Elizabeth J.
Palmateer, Norah E.
Hutchinson, Sharon J.
Cameron, Sheila
Goldberg, David J.
and
Taylor, Avril
2012.
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
International Journal of Drug Policy,
Vol. 23,
Issue. 5,
p.
346.